Zevra Therapeutics (ZVRA)
Zevra Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
6.2M
Short interest
settlement 2026-10-15
7.1
Days to cover
-0.1 days vs prior
60.4%
Short share of volume
2026-11-02
103
Fails to deliver
settlement 2026-10-13
Wed 4 Nov
Next earnings
estimated date
-$838K
Insider flow, 90 days
0 buys, 3 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ZVRA is 6,226,029 shares, up 487,366 shares over the last month. Over the last 48 readings it ranged from 3,937,545 shares (31 October 2024) to 9,067,314 shares (30 September 2025). At the reported average volume of 879K shares a day that is 7.1 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/zvra" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 6,226,029 | -12.9% | 879,203 | 7.08 |
| 2026-09-30 | 7,147,220 | +24.6% | 998,161 | 7.16 |
| 2026-09-15 | 5,738,663 | -0.6% | 905,980 | 6.33 |
| 2026-08-31 | 5,771,206 | -10.8% | 773,319 | 7.46 |
| 2026-08-14 | 6,470,662 | -9.3% | 1,123,912 | 5.76 |
| 2026-07-31 | 7,131,888 | -8.5% | 1,622,451 | 4.40 |
| 2026-07-15 | 7,795,667 | +20.1% | 1,433,774 | 5.44 |
| 2026-06-30 | 6,490,132 | -0.5% | 1,504,942 | 4.31 |
| 2026-06-15 | 6,520,146 | +9.3% | 2,334,040 | 2.79 |
| 2026-05-29 | 5,964,448 | +34.2% | 2,178,038 | 2.74 |
| 2026-05-15 | 4,443,028 | -10.8% | 1,762,224 | 2.52 |
| 2026-04-30 | 4,980,614 | +4.3% | 812,124 | 6.13 |
| 2026-04-15 | 4,776,072 | +7.6% | 664,627 | 7.19 |
| 2026-03-31 | 4,439,076 | -6.0% | 921,743 | 4.82 |
| 2026-03-13 | 4,719,963 | -12.8% | 2,135,969 | 2.21 |
| 2026-02-27 | 5,414,878 | +9.2% | 627,187 | 8.63 |
| 2026-02-13 | 4,960,672 | +3.4% | 742,099 | 6.68 |
| 2026-01-30 | 4,797,728 | +20.2% | 965,487 | 4.97 |
| 2026-01-15 | 3,991,736 | -32.5% | 1,084,209 | 3.68 |
| 2025-12-31 | 5,910,789 | -14.2% | 909,463 | 6.50 |
| 2025-12-15 | 6,888,482 | -0.7% | 982,309 | 7.01 |
| 2025-11-28 | 6,934,119 | -10.3% | 1,382,092 | 5.02 |
| 2025-11-14 | 7,734,477 | +8.9% | 1,920,501 | 4.03 |
| 2025-10-31 | 7,103,776 | -11.1% | 1,109,390 | 6.40 |
| 2025-10-15 | 7,991,725 | -11.9% | 2,334,833 | 3.42 |
| 2025-09-30 | 9,067,314 | +22.5% | 3,140,970 | 2.89 |
| 2025-09-15 | 7,399,962 | +7.3% | 1,310,873 | 5.65 |
| 2025-08-29 | 6,894,109 | +8.4% | 1,221,402 | 5.64 |
| 2025-08-15 | 6,357,218 | +37.0% | 1,922,772 | 3.31 |
| 2025-07-31 | 4,641,411 | -5.2% | 1,033,909 | 4.49 |
| 2025-07-15 | 4,895,563 | -2.0% | 1,795,364 | 2.73 |
| 2025-06-30 | 4,993,420 | +6.0% | 528,823 | 9.44 |
| 2025-06-13 | 4,711,373 | -16.9% | 632,834 | 7.44 |
| 2025-05-30 | 5,669,892 | -5.7% | 586,837 | 9.66 |
| 2025-05-15 | 6,009,168 | +7.3% | 627,350 | 9.58 |
| 2025-04-30 | 5,600,724 | -5.4% | 376,590 | 14.87 |
| 2025-04-15 | 5,921,035 | +0.2% | 576,138 | 10.28 |
| 2025-03-31 | 5,907,650 | +6.0% | 459,287 | 12.86 |
| 2025-03-14 | 5,573,115 | -0.7% | 566,258 | 9.84 |
| 2025-02-28 | 5,612,280 | -2.9% | 318,062 | 17.65 |
| 2025-02-14 | 5,776,931 | +4.6% | 333,858 | 17.30 |
| 2025-01-31 | 5,522,234 | +0.9% | 431,425 | 12.80 |
| 2025-01-15 | 5,473,371 | +17.3% | 440,993 | 12.41 |
| 2024-12-31 | 4,668,012 | +14.7% | 587,124 | 7.95 |
| 2024-12-13 | 4,071,515 | -5.4% | 412,476 | 9.87 |
| 2024-11-29 | 4,305,541 | +4.7% | 539,157 | 7.99 |
| 2024-11-15 | 4,112,391 | +4.4% | 765,455 | 5.37 |
| 2024-10-31 | 3,937,545 | -21.2% | 456,695 | 8.62 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of ZVRA volume is 60.4%, down 2.5 points over the last five sessions. Over the last 30 readings it ranged from 33.1% (28 September 2026) to 85.5% (29 September 2026). The latest reading is in line with the 30-session average of 61.1%, on 179K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 108K | 179K | 60.4% | 201 |
| 2026-10-30 | 123K | 191K | 64.6% | 70 |
| 2026-10-29 | 71K | 126K | 56.3% | 0 |
| 2026-10-28 | 306K | 425K | 72.1% | 336 |
| 2026-10-27 | 401K | 548K | 73.2% | 0 |
| 2026-10-26 | 183K | 290K | 62.9% | 0 |
| 2026-10-23 | 326K | 442K | 73.8% | 1 |
| 2026-10-22 | 90K | 138K | 65.3% | 25 |
| 2026-10-21 | 85K | 138K | 61.4% | 205 |
| 2026-10-20 | 69K | 127K | 54.4% | 150 |
| 2026-10-19 | 126K | 182K | 69.4% | 175 |
| 2026-10-16 | 95K | 202K | 47.1% | 0 |
| 2026-10-15 | 63K | 147K | 42.7% | 11 |
| 2026-10-14 | 108K | 258K | 42.0% | 0 |
| 2026-10-13 | 178K | 455K | 39.0% | 0 |
| 2026-10-12 | 130K | 190K | 68.3% | 1 |
| 2026-10-09 | 199K | 274K | 72.5% | 925 |
| 2026-10-08 | 95K | 144K | 65.5% | 3 |
| 2026-10-07 | 257K | 359K | 71.5% | 60 |
| 2026-10-06 | 148K | 213K | 69.2% | 0 |
| 2026-10-05 | 738K | 873K | 84.6% | 10,906 |
| 2026-10-02 | 204K | 373K | 54.5% | 0 |
| 2026-10-01 | 224K | 372K | 60.1% | 500 |
| 2026-09-30 | 313K | 485K | 64.6% | 0 |
| 2026-09-29 | 714K | 835K | 85.5% | 0 |
| 2026-09-28 | 98K | 297K | 33.1% | 1 |
| 2026-09-25 | 114K | 291K | 39.0% | 0 |
| 2026-09-24 | 115K | 185K | 61.9% | 0 |
| 2026-09-23 | 140K | 261K | 53.7% | 0 |
| 2026-09-22 | 162K | 252K | 64.2% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in ZVRA is 103 shares, down 1,692 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (8 July 2026) to 172,544 shares (27 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 103 | $11.32 | $1K |
| 2026-09-30 | 1,795 | $11.34 | $20K |
| 2026-09-11 | 19,240 | $12.06 | $232K |
| 2026-09-10 | 21,810 | $12.04 | $263K |
| 2026-09-09 | 21,834 | $12.68 | $277K |
| 2026-09-08 | 22,537 | $12.40 | $279K |
| 2026-09-04 | 20,474 | $12.54 | $257K |
| 2026-09-03 | 20,843 | $12.30 | $256K |
| 2026-08-18 | 219 | $11.53 | $3K |
| 2026-08-12 | 46 | $11.34 | $522 |
| 2026-08-07 | 538 | $11.88 | $6K |
| 2026-07-29 | 9,484 | $9.73 | $92K |
| 2026-07-27 | 172,544 | $9.53 | $1.6M |
| 2026-07-20 | 9,395 | $12.77 | $120K |
| 2026-07-16 | 64 | $12.96 | $829 |
| 2026-07-14 | 15 | $13.18 | $198 |
| 2026-07-08 | 2 | $14.44 | $29 |
| 2026-07-02 | 1,213 | $13.81 | $17K |
| 2026-06-30 | 16,262 | $14.01 | $228K |
| 2026-06-18 | 4,254 | $12.61 | $54K |
| 2026-06-09 | 2,906 | $12.09 | $35K |
| 2026-06-05 | 3 | $11.17 | $34 |
| 2026-06-02 | 705 | $11.49 | $8K |
| 2026-06-01 | 15,797 | $11.59 | $183K |
| 2026-05-19 | 9,440 | $10.43 | $98K |
| 2026-05-18 | 820 | $11.01 | $9K |
| 2026-05-11 | 1,093 | $11.13 | $12K |
| 2026-04-28 | 53 | $9.81 | $520 |
| 2026-04-21 | 207 | $10.78 | $2K |
| 2026-04-20 | 1,000 | $10.67 | $11K |
Insider trades
SEC Form 4, newest first. JSONInsiders at ZVRA reported 3 open-market sells worth $838K in the last 90 days and no open-market buys. Latest filing: McFarlane Neil F. (President and CEO) on 2026-10-12.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | McFarlane Neil F. | President and CEO | Sell | 20K | $11.25 | $225K | 417K |
| 2026-10-10 | McFarlane Neil F. | President and CEO | Exercise or conversion | 50K | price not stated in the filing | not stated | 437K |
| 2026-08-14 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 43K | $11.13 | $475K | 38K |
| 2026-08-10 | Watton Corey Michael | Director | Sell | 12K | $11.25 | $138K | 2K |
| 2026-08-10 | Watton Corey Michael | Director | Exercise or conversion | 12K | $4.97 | $61K | 14K |
| 2026-06-22 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 35K | $12.68 | $438K | 80K |
| 2026-06-21 | Thompson Rahsaan | Chief Legal & Compliance | Exercise or conversion | 67K | price not stated in the filing | not stated | 115K |
| 2026-05-11 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 2K | $11.30 | $20K | 48K |
| 2026-03-24 | Bode John B | Director | Exercise or conversion | 39K | $4.89 | $192K | 123K |
| 2026-03-24 | Bode John B | Director | Exercise or conversion | 39K | $4.97 | $195K | 84K |
| 2026-02-09 | McFarlane Neil F. | President and CEO | Sell | 15K | $8.56 | $125K | 387K |
| 2026-02-07 | McFarlane Neil F. | President and CEO | Exercise or conversion | 38K | price not stated in the filing | not stated | 402K |
| 2026-02-03 | Schafer Joshua | CCO | Sell | 11K | $9.19 | $97K | 62K |
| 2026-02-03 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | 3K | $9.18 | $28K | 30K |
| 2026-02-02 | McFarlane Neil F. | President and CEO | Sell | 91K | $9.38 | $854K | 364K |
| 2026-01-31 | McFarlane Neil F. | President and CEO | Exercise or conversion | 233K | price not stated in the filing | not stated | 455K |
| 2026-01-31 | Schafer Joshua | CCO | Exercise or conversion | 35K | price not stated in the filing | not stated | 73K |
| 2026-01-31 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Exercise or conversion | 12K | price not stated in the filing | not stated | 33K |
| 2026-01-30 | Schafer Joshua | CCO | Sell | 3K | $8.83 | $30K | 37K |
| 2026-01-30 | Schafer Joshua | CCO | Exercise or conversion | 11K | price not stated in the filing | not stated | 41K |
| 2026-01-30 | Quartel Adrian W | Chief Medical Officer | Exercise or conversion | 11K | price not stated in the filing | not stated | 14K |
| 2026-01-30 | Quartel Adrian W | Chief Medical Officer | Sell | 5K | $8.83 | $40K | 10K |
| 2026-01-30 | Thompson Rahsaan | Chief Legal & Compliance | Exercise or conversion | 11K | price not stated in the filing | not stated | 54K |
| 2026-01-30 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 4K | $8.83 | $36K | 50K |
| 2026-01-30 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Exercise or conversion | 6K | price not stated in the filing | not stated | 23K |
| 2026-01-30 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | 2K | $8.82 | $15K | 21K |
| 2025-12-31 | Clifton R. LaDuane | Former CFO & Treasurer | Tax withholding | 49K | $8.96 | $435K | 144K |
| 2025-12-31 | Clifton R. LaDuane | Former CFO & Treasurer | Exercise or conversion | 141K | $0.00 | $0 | 192K |
| 2025-10-10 | McFarlane Neil F. | President and CEO | Sell | 20K | $10.82 | $211K | 222K |
| 2025-10-10 | McFarlane Neil F. | President and CEO | Exercise or conversion | 50K | price not stated in the filing | not stated | 242K |
| 2025-09-12 | Shih Alvin | Director | Buy | 20K | $7.89 | $158K | 20K |
| 2025-09-12 | FAVORITO TAMARA A | Director | Buy | 3K | $7.79 | $25K | 4K |
| 2025-08-19 | Bode John B | Director | Buy | 5K | $9.16 | $46K | 45K |
| 2025-06-26 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 24K | $9.21 | $221K | 43K |
| 2025-06-21 | Thompson Rahsaan | Chief Legal & Compliance | Exercise or conversion | 67K | price not stated in the filing | not stated | 67K |
| 2025-03-28 | Watton Corey Michael | Director | Buy | 300 | $7.84 | $2K | 2K |
| 2025-03-19 | Bode John B | Director | Buy | 10K | $7.96 | $80K | 40K |
| 2025-02-14 | McFarlane Neil F. | President and CEO | Sell | 31K | $8.05 | $246K | 192K |
| 2025-02-13 | McFarlane Neil F. | President and CEO | Sell | 61K | $7.86 | $482K | 222K |
| 2025-02-13 | Clifton R. LaDuane | CFO & Treasurer | Sell | 11K | $7.86 | $86K | 51K |
| 2025-02-13 | Schafer Joshua | CCO & EVP, Bus. Development | Sell | 11K | $7.86 | $83K | 29K |
| 2025-02-13 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | 3K | $7.86 | $24K | 16K |
| 2025-01-31 | McFarlane Neil F. | President and CEO | Exercise or conversion | 233K | price not stated in the filing | not stated | 283K |
| 2025-01-31 | Clifton R. LaDuane | CFO & Treasurer | Exercise or conversion | 43K | price not stated in the filing | not stated | 62K |
| 2025-01-31 | Schafer Joshua | CCO & EVP, Bus. Development | Exercise or conversion | 35K | price not stated in the filing | not stated | 40K |
| 2025-01-31 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Exercise or conversion | 12K | price not stated in the filing | not stated | 19K |
| 2024-10-11 | Watton Corey Michael | Director | Buy | 500 | $7.92 | $4K | 2K |
| 2024-07-17 | Clifton R. LaDuane | CFO & Treasurer | Buy | 2K | $6.77 | $14K | 18K |
| 2024-07-16 | Anderson Thomas | Director | Buy | 10K | $6.81 | $68K | 20K |
| 2024-07-12 | Bode John B | Director | Buy | 10K | $5.87 | $59K | 30K |
| 2023-09-06 | Anderson Thomas | Director | Buy | 10K | $4.88 | $49K | 10K |
| 2023-09-06 | Clifton R. LaDuane | CFO, Secretary & Treasurer | Buy | 1K | $4.96 | $5K | 15K |
| 2023-09-05 | Bode John B | Director | Buy | 10K | $5.13 | $51K | 20K |
| 2023-09-05 | Schafer Joshua | CCO & EVP, Bus. Development | Buy | 500 | $5.13 | $3K | 4K |
| 2023-06-23 | Watton Corey Michael | Director | Buy | 275 | $5.95 | $2K | 1K |
| 2023-06-09 | Watton Corey Michael | Director | Buy | 325 | $5.52 | $2K | 725 |
| 2023-05-30 | Watton Corey Michael | Director | Buy | 400 | $5.11 | $2K | 400 |
| 2023-05-19 | Schafer Joshua | CCO & EVP, Bus. Development | Buy | 1K | $5.42 | $5K | 3K |
| 2023-05-18 | Clifton R. LaDuane | CFO, Secretary & Treasurer | Buy | 689 | $4.95 | $3K | 14K |
| 2023-05-18 | Clifton R. LaDuane | CFO, Secretary & Treasurer | Buy | 51 | $4.94 | $252 | 11K |
| 2023-05-18 | Clifton R. LaDuane | CFO, Secretary & Treasurer | Buy | 2K | $4.95 | $10K | 13K |
| 2023-05-18 | Bode John B | Director | Buy | 2K | $5.05 | $12K | 10K |
| 2023-05-18 | Bode John B | Director | Buy | 100 | $5.05 | $505 | 8K |
| 2023-05-18 | Bode John B | Director | Buy | 5K | $5.04 | $24K | 7K |
| 2023-05-18 | Bode John B | Director | Buy | 1K | $5.04 | $5K | 3K |
| 2023-05-18 | Bode John B | Director | Buy | 300 | $5.04 | $2K | 2K |
| 2023-05-18 | Bode John B | Director | Buy | 1K | $5.04 | $7K | 1K |
| 2023-03-17 | SEYMOUR TAMARA A | Director | Buy | 519 | $4.82 | $3K | 719 |
| 2023-03-14 | Schafer Joshua | CCO & EVP, Bus. Development | Buy | 2K | $4.61 | $9K | 2K |
| 2023-03-10 | Clifton R. LaDuane | CFO, Secretary & Treasurer | Buy | 2K | $4.15 | $7K | 11K |
| 2023-03-10 | Sangiovanni Timothy J. | SVP, Corporate Controller | Buy | 100 | $4.14 | $414 | 4K |
| 2023-03-10 | Sangiovanni Timothy J. | SVP, Corporate Controller | Buy | 1K | $4.14 | $5K | 4K |
| 2023-03-09 | Pascoe Richard W | Chief Executive Officer | Buy | 10K | $4.20 | $42K | 30K |
| 2023-03-09 | Tierney David S | Director | Buy | 5K | $4.15 | $21K | 11K |
| 2023-03-09 | Plooster Matthew R | Director | Buy | 11K | $4.20 | $46K | 19K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON12 Form 144 notices on file for ZVRA worth $6.2M at the prices reported; 2 in the last 90 days worth $705K. Latest: NEIL F MCFARLANE filed on 2026-10-13 to sell 20,000 shares ($228K) from 2026-10-12.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-13 | NEIL F MCFARLANEDirector, Officer | 20K | $228K | 0.034% | 2026-10-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-14 | RAHSAAN THOMPSONOfficer, Secretary | 43K | $477K | 0.072% | 2026-08-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-08 | JOHN BODEDirector | 11K | $156K | 0.018% | 2026-07-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-11 | Rahsaan ThompsonOfficer, Chief Legal & Compliance / Secretary | 36K | $405K | 0.061% | 2026-05-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-16 | RAYMOND L CLIFTONOfficer | 345K | $3.4M | 0.588% | 2026-03-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-02 | NEIL F MCFARLANEDirector, Officer | 106K | $951K | 0.188% | 2026-02-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-30 | RAHSAAN THOMPSONOfficer, Secretary | 4K | $36K | 0.007% | 2026-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-30 | JOSHUA SCHAFEROfficer | 14K | $123K | 0.025% | 2026-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-30 | TIMOTHY SANGIOVANNIOfficer | 5K | $42K | 0.008% | 2026-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-30 | ADRIAN QUARTELOfficer | 5K | $40K | 0.008% | 2026-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-30 | R LaDuane CliftonFormer CFO & Treasurer | 14K | $124K | 0.025% | 2026-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-10 | NEIL F MCFARLANEDirector, Officer | 20K | $211K | 0.035% | 2025-10-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of ZVRA in their latest filing, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 8.3% of the class (4,915,717 shares), filed 2026-08-06 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 2 | Woodline Partners LPinvestment adviser, partnership | 4.8M | 8.1% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 1 | FMR LLCparent holding company | 4.9M | 8.3% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 4.9M | 8.3% | 2026-06-30 |
| 2026-07-31 | 13G | Vanguard Capital Managementinvestment adviser | 3.0M | 5.1% | 2026-06-30 |
| 2026-03-27 | 13G/Ano. 2 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-11-13 | 13G/Ano. 1 | Adage Capital Management, L.P.investment adviser, partnership | 2.2M | 4.0% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | Robert Atchinsonparent holding company, individual | 2.2M | 4.0% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | Phillip Grossparent holding company, individual | 2.2M | 4.0% | 2025-09-30 |
13F holders
Tracked managers holding ZVRA at their latest 13F. JSON5 of the 30 tracked managers held ZVRA at their latest 13F, $23.9M in total at quarter-end prices. D. E. Shaw & Co. is the largest at $18.7M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 1.3M | $18.7M | 0.01% | +460K |
| AQR Capital Management | 2026-06-30 | 191K | $2.7M | 0.00% | +111K |
| Millennium Management | 2026-06-30 | 90K | $1.3M | 0.00% | -500K |
| Two Sigma Investments | 2026-06-30 | 65K | $935K | 0.00% | +13K |
| Citadel Advisors | 2026-06-30 | 12K | $174K | 0.00% | -615K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Zevra Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Zevra Therapeutics (ZVRA), SEC CIK 1434647, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-13.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-12.JSON and CSV
- Company record
- EDGAR filing index for CIK 1434647Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of ZVRA is sold short?
6,226,029 shares were held short at the 2026-10-15 settlement, 7.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ZVRA's daily short volume?
On 2026-11-02, 108,383 of the 179,323 ZVRA shares reported to FINRA were sold short, 60.4% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ZVRA have fails to deliver?
The SEC's latest file shows 103 ZVRA shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are ZVRA insiders buying or selling?
Insiders at ZVRA reported 3 open-market sells worth $838K in the last 90 days and no open-market buys. Latest filing: McFarlane Neil F. (President and CEO) on 2026-10-12.
Have ZVRA insiders filed to sell?
12 Form 144 notices on file for ZVRA worth $6.2M at the prices reported; 2 in the last 90 days worth $705K. Latest: NEIL F MCFARLANE filed on 2026-10-13 to sell 20,000 shares ($228K) from 2026-10-12.
Who owns 5% or more of ZVRA?
4 holders report 5% or more of ZVRA in their latest filing, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 8.3% of the class (4,915,717 shares), filed 2026-08-06 for an event on 2026-06-30.
Which tracked 13F managers own ZVRA?
5 of the 30 tracked 13F managers held ZVRA shares at their latest filing, $23.9M in all. The largest: D. E. Shaw & Co. (1.3M shares, $18.7M), Cliff Asness's AQR Capital Management (191K shares, $2.7M), Izzy Englander's Millennium Management (90K shares, $1.3M), Two Sigma Investments (65K shares, $935K), Ken Griffin's Citadel Advisors (12K shares, $174K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.